Get the Stockscreener App
20.33
0.49%
0.10
After Hours:
20.33
Orthopediatrics Corp stock is traded at $20.33, with a volume of 57,326.
It is up +0.49% in the last 24 hours and up +10.13% over the past month.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
See More
Previous Close:
$20.23
Open:
$20.29
24h Volume:
57,326
Relative Volume:
0.37
Market Cap:
$522.18M
Revenue:
$243.30M
Net Income/Loss:
$-39.68M
P/E Ratio:
-12.08
EPS:
-1.6825
Net Cash Flow:
$-14.64M
1W Performance:
+1.90%
1M Performance:
+10.13%
6M Performance:
+11.03%
1Y Performance:
-9.44%
1-Day Range:
$19.93
$20.45
1-Week Range:
$19.37
$21.40
52-Week Range:
$14.42
$23.70
Orthopediatrics Corp Stock (KIDS) Company Profile
Name
Orthopediatrics Corp
Sector
Industry
Phone
574-268-6379
Address
2850 FRONTIER DRIVE, WARSAW, IN
Compare KIDS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KIDS
Orthopediatrics Corp
|
20.33 | 522.18M | 243.30M | -39.68M | -14.64M | -1.6825 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthopediatrics Corp Stock (KIDS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Dec-10-25 | Initiated | Canaccord Genuity | Buy |
| Apr-07-25 | Initiated | Lake Street | Buy |
| Jan-25-24 | Downgrade | Truist | Buy → Hold |
| Jun-14-21 | Reiterated | Needham | Buy |
| Apr-02-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jun-19-19 | Initiated | Needham | Buy |
| Feb-20-19 | Initiated | JMP Securities | Mkt Outperform |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
View All
Orthopediatrics Corp Stock (KIDS) Latest News
Precision Trading with Orthopediatrics Corp. (KIDS) Risk Zones - Stock Traders Daily
OrthoPediatrics Corp focuses on pediatric orthopedic growth as KIDS stock tracks sector trends - ad-hoc-news.de
ROSEN, A TOP RANKED LAW FIRM, Continues to Investigate Securitie - GuruFocus
Enterprise value to EBITDA forward of OrthoPediatrics Corp. – NASDAQ:KIDS - TradingView
OrthoPediatrics | 8-K: OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results - Moomoo
OrthoPediatrics Corp.(NasdaqGM: KIDS) added to Russell 2000 Value-Defensive Index - marketscreener.com
OrthoPediatrics Corp.(NasdaqGM: KIDS) added to Russell 2000 Growth-Defensive Index - marketscreener.com
World Ortho Pediatric DevicesMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
OrthoPediatrics Corp.(NasdaqGM: KIDS) added to Russell 2000 Defensive Index - marketscreener.com
Price to sales forward of OrthoPediatrics Corp. – NASDAQ:KIDS - TradingView
Enterprise value to EBITDA forward of OrthoPediatrics Corp. – LSX:A2JAAV - TradingView
Enterprise value to EBIT forward of OrthoPediatrics Corp. – NASDAQ:KIDS - TradingView
Enterprise value to EBIT forward of OrthoPediatrics Corp. – LSX:A2JAAV - TradingView
Enterprise value to revenue forward of OrthoPediatrics Corp. – NASDAQ:KIDS - TradingView
Price to book forward of OrthoPediatrics Corp. – LSX:A2JAAV - TradingView
OrthoPediatrics Corp Friday sector view, shares in a specialized medtech niche - ad-hoc-news.de
OrthoPediatrics Corp (KIDS) Valuation: PE, PB & Fair Value Analysis - TradingKey
OrthoPediatrics Corp. Actuals & Estimates (NASDAQ:KIDS) - TradingView
KIDS Forecast — Price Target — Prediction for 2027 - TradingView
OrthoPediatrics’ Shift to Sterile Packaging Streamlines Pediatric Implant Care - Healthcare Packaging
OrthoPediatrics (KIDS) Stock Sees Split Analyst Revisions After Mixed Price Target Changes - Yahoo Finance
Orthopediatrics Corp announces a distribution agreement with Ossio, Inc. to introduce revolutionary orthopedic fixation technology to children's hospitals across the United States - Bitget
OSSIO Inc.’s Distribution Deal With OrthoPediatrics Corp. Brings Bio-Integrative, Metal-Free OSSIOfiber® Implants to U.S. Children’s Hospitals Nationwide - Ortho Spine News
OrthoPediatrics lands metal-free implant deal - beckersspine.com
OrthoPediatrics partners with OSSIO for bio-integrative implants - Investing.com
OrthoPediatrics adds metal-free implants for children’s hospitals - Stock Titan
OrthoPediatrics partners with OSSIO for bio-integrative implants By Investing.com - Investing.com Canada
UNFO and OrthoPediatrics Partner to Bring Non-Invasive Foot Brace for Newborns to U.S. Market - Yahoo Finance
OrthoPediatrics Corp.(NasdaqGM:KIDS) dropped from S&P Healthcare Equipment Select Industry Index - marketscreener.com
Tranche Update on OrthoPediatrics Corp.'s Equity Buyback Plan announced on August 5, 2024. - marketscreener.com
OrthoPediatrics Corp (KIDS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OrthoPediatrics Corp (KIDS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OrthoPediatrics Corp (KIDS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OrthoPediatrics Corp (KIDS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TD Cowen reiterates OrthoPediatrics stock Buy rating at $23 target By Investing.com - Investing.com India
TD Cowen reiterates OrthoPediatrics stock Buy rating at $23 target - Investing.com
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Operational Efficiency - newsline.com
OrthoPediatrics Corp. (KIDS) Holds Steady Near Support Amidst Minimal MovementWeak Sell Signals - newsline.com
KIDS SEC FilingsOrthopedia 10-K, 10-Q, 8-K Forms - Stock Titan
OrthoPediatrics (KIDS) director receives 11,436-share stock award - Stock Titan
[Form 4] ORTHOPEDIATRICS CORP Insider Trading Activity - Stock Titan
Director Kelly Laine Fischer receives 11,436-share grant at Orthopediatrics (NASDAQ: KIDS) - Stock Titan
Orthopediatrics (NASDAQ: KIDS) director awarded 11,436 shares in new stock grant - Stock Titan
Stock award lifts OrthoPediatrics (KIDS) director Harold Ruf holdings - Stock Titan
OrthoPediatrics (KIDS) awards new stock grant to director - Stock Titan
OrthoPediatrics Corp stock (US68735M1027): pediatric implant specialist in focus after latest earnin - AD HOC NEWS
Why The OrthoPediatrics (KIDS) Narrative Is Evolving Without A New Price Target - Yahoo Finance
OrthoPediatrics Corp. (KIDS) Q1 2026 Earnings: Narrower Loss Beats Estimates as Pediatric Orthopedic Portfolio AdvancesMargin Expansion Trends - newsline.com
OrthoPediatrics Corp. (KIDS) Gains Ground as Market Eyes Key ResistancePrice Action Signals - newsline.com
(KIDS) Volatility Zones as Tactical Triggers - Stock Traders Daily
OrthoPediatrics Corp. Files 8-K Report Detailing Executive Compensation and Auditor Approval – June 2026 - Minichart
Orthopediatrics Corp Stock (KIDS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orthopediatrics Corp Stock (KIDS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hite Fred | COO and CFO |
Mar 16 '26 |
Sale |
17.25 |
12,993 |
224,129 |
277,477 |
| Bailey David R | President and CEO |
Mar 16 '26 |
Sale |
17.25 |
19,535 |
336,979 |
298,020 |
| Odle Gregory A | President of Scoliosis |
Mar 16 '26 |
Sale |
17.25 |
8,433 |
145,469 |
187,735 |
| Gerritzen Daniel J | General Counsel and Secretary |
Mar 16 '26 |
Sale |
17.25 |
8,614 |
148,592 |
149,533 |
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):